Abstract: Objective: COVID-19 is a respiratory disease associated with high mortality that emerged in December 2019. Individuals with preexisting health conditions, such as heart disease, hypertension, diabetes, and chronic obstructive pulmonary disease, and those with weakened immune systems are at increased risk for severe complications. Cancer patients have been adversely affected by the pandemic, both due to the disease itself and its treatments. The aim of this study is to evaluate the impact of COVID-19 on mortality in cancer patients admitted to the intensive care unit (ICU). Material and Methods: We conducted a retrospective analysis of 274 COVID-19 patients who were admitted to the ICU between January 2020 and April 2022. Among these patients, 72 had a cancer diagnosis and were classified into two groups: Group 1 (n=203) included patients without cancer, and Group 2 (n=72) included patients with cancer. We recorded age, gender, comorbidities, PCR test results, laboratory parameters, APACHE2 and SOFA scores, duration of ICU stay, mechanical ventilation requirement, and duration of mechanical ventilation for all patients. Results: Hypertension was significantly more common in Group 1 compared to Group 2 [(297 (48%) and 24 (33%), respectively); p

Amaç: Şok indeksleri özellikle hemorajik şok durumunda transfüzyonu ön görmede kullanılmaktadır. Ancak sepsis hastalarında transfüzyonu belirlemek için şok indekslerinin kullanımı konusunda yeterli çalışma yoktur. Çalışmamızda yoğun bakım ünitesine (YBÜ) yatan sepsis ve septik şoktaki hastalarda şok indeksi (SI), modifiye şok indeksi (MSI) ve yaş şok indeksinin (YSI) hastaların eritrosit transfüzyonunu ön görmede kullanılabilirliğinin araştırılması amaçlanmıştır.